TINA RAHE: Open Payments
NPI 1235911678 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 113 payments from 18 companies in 2025. Trend: 2023 $17 · 2024 $331 · 2025 $3,048
Food & beverage: $3,048
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $437 |
| Otsuka America Pharmaceutical, Inc. | 8 | $397 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $342 |
| ABBVIE INC. | 17 | $338 |
| Alkermes, Inc. | 14 | $295 |
| Vanda Pharmaceuticals Inc. | 8 | $248 |
| Axsome Therapeutics, Inc. | 7 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $173 |
| E.R. Squibb & Sons, L.L.C. | 2 | $141 |
| Corium, LLC | 6 | $130 |
Products named: REXULTI, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, ARISTADA, Auvelity, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
